By proceeding, you agree to our Terms of Use and Privacy Policy.
Cellecta provides HT loss-of-function genetic screening services for the discovery and functional characterization of novel therapeutic targets.
17-20 October 2022
Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules. We
Event Ended
Hybrid
Paid
Boston
25-28 September 2023
Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.